Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Multivariate analysis: breast and bowel screening uptakes by age group and gender

From: Breast and bowel cancer screening uptake patterns over 15 years for UK south Asian ethnic minority populations, corrected for differences in socio-demographic characteristics

Cancer screening Programme/Round Age Number Uptake (%) Adjusted OR (95% CI)
  50–54 17453 77.13 1 (-)
  55–59 20307 76.63 0.97+ (0.92, 1.02)
Breast screening 60–64 20081 72.16 0.78** (0.74, 0.82)
Round 1: 1989–92 65–69 4051 68.28 0.65** (0.60, 0.71)
  50–54 19176 78.99 1 (-)
  55–59 20894 78.15 0.96+ (0.91, 1.01)
Breast screening 60–64 19144 74.68 0.79** (0.75, 0.83)
Round 2: 1992–95 65–69 3577 69.33 0.61** (0.56, 0.67)
  50–54 26909 78.71 1 (-)
  55–59 26175 78.93 1.00+ (0.96, 1.04)
Breast screening 60–64 19733 76.93 0.91** (0.87, 0.95)
Round 5: 2001–04 65–69 13394 73.32 0.75** (0.71, 0.79)
  50 – 54 36832 54.74 1 (-)
  55 – 59 34931 29.30 1.18** (1.15, 1.22)
Bowel screening 60 – 64 27518 62.58 1.41** (1.36, 1.45)
Round 1: 2000–02 65 – 69 23968 64.86 1.56** (1.51, 1.61)
  50 – 54 32426 47.44 1 (-)
  55 – 59 34309 52.88 1.21** (1.17, 1.24)
Bowel screening 60 – 64 27336 57.69 1.49** (1.44, 1.54)
Round 2: 2003–05 65 – 69 22588 61.44 1.77** (1.71, 1.84)
Cancer screening Programme/Round Gender Number Uptake (%) Adjusted OR (95% CI)
Bowel screening Male 61650 55.30 1 (-)
Round 1: 2000–02 Female 61599 64.21 1.46** (1.43, 1.50)
Bowel screening Male 58395 50.08 1 (-)
Round 2: 2003–05 Female 58264 58.21 1.39** (1.36, 1.43)
  1. +Non-significant p > 0.05
  2. ** Significant at p < 0.001